The most important financial indicators for the company Optimapharm Research Ro S.r.l. - Unique Identification Number 11268190:
sales in 2023 was
1.217.154
euro, registering a net profit of
81.624
euro and having an average number of
8
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -60.8%, from 3.112.494 euro in the year 2022, to 1.217.154 euro in 2023.
The Net Profit decreased by -318.270 euro, from 401.111 euro in 2022, to 81.624 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Optimapharm Research Ro S.r.l. - CUI 11268190
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
134.265
117.595
14.821
8.838
3.818
2.282
4.605
7.780
9.625
4.992
Current Assets
97.406
80.136
144.680
172.655
152.413
132.060
153.249
197.176
1.705.859
1.444.394
Inventories
0
127
508
0
0
0
0
558
2.611
8.668
Receivables
31.206
33.739
89.683
59.167
61.417
52.613
111.196
104.446
328.458
1.219.080
Cash
66.200
46.270
54.489
113.488
90.996
79.447
42.054
92.172
1.374.790
216.647
Shareholders Funds
134.668
124.008
66.873
78.048
97.912
101.356
104.004
141.497
543.047
623.024
Social Capital
78.088
78.740
77.937
76.618
75.212
73.756
72.357
70.753
70.972
70.757
Debts
97.003
73.723
100.644
103.445
58.319
32.986
53.851
63.459
1.147.203
766.853
Income in Advance
0
0
0
0
0
0
0
0
703
140
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.444.394 euro in 2023 which includes Inventories of
8.668 euro, Receivables of
1.219.080 euro and cash availability of
216.647 euro.
The company's Equity was valued at
623.024 euro, while total Liabilities amounted to
766.853 euro.
Equity increased by 81.624 euro, from 543.047 euro in 2022, to 623.024 in 2023.
The Debt Ratio was 55.2% in the year 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Optimapharm Research Ro S.r.l.